A potential approach to treatment of hepatitis B virus infection

Sep 10, 2008

Eukaryotic cells employ multiple strategies of checkpoint signaling and DNA repair mechanisms to monitor and repair damaged DNA. There are two branches in the checkpoint response pathway—ataxia telangiectasia-mutated (ATM) and ATM-Rad3-related (ATR). Many viruses are now known to interact with DNA damage sensing and repair machinery.

These viruses have evolved tactics to eliminate, circumvent, or exploit various aspects of the DNA damage response of the host cell. Strategies include the activation of repair proteins or the targeting of specific cellular factors for degradation or mislocalization. Exploiting the activation of the DNA damage pathway by viral replication for the generation of antiviral drugs needs to be examined.

In the human immunodeficiency virus (HIV), it has been clearly determined that the prevention of viral integration inhibits viral replication and promotes cellular apoptosis. Thus, the ATM-specific inhibitor ku55933 can inhibit HIV replication in primary T cells.

Despite the availability of a safe and efficient vaccine, chronic hepatitis B virus infection remains a major health problem worldwide. Interferon treatment is effective in only approximately one-third of the patients and produces considerable side effects. Long-term treatment with the second-generation nucleoside analogue lamivudine (lam) efficiently inhibits HBV replication with frequent viral polymerase mutations. We found that HBV infection triggered an ATR-dependent DNA damage response, resulting in increased ATR and Chk1 phosphorylation levels, however, ATR checkpoint signaling was blocked downstream of the p53-dependent pathway to evade apoptosis by p21 degradation. We have designed a strategy to select new drug targets that inhibit a cellular gene required for HBV replication or restore a response stalled by HBV in the ATR DNA damage pathway.

A research article to be published on August 28, 2008 in the World Journal of Gastroenterology addresses this question. The research team led by Professor, Zhong from Beijing Institute of Biotechnology used report that HBV infection activates and exploits the DNA damage response to replication stress. They investigated whether the inhibition of DNA damage response by CF, TP and UCN01 or the restoration of p21 expression by p21 transfection or proteasome inhibition would lead to suppressed HBV replication.

They set up a chronic HBV infection model by culturing hepatocyte HL7702 cells with HBV-positive serum without washing off input virus as conventional. HBV DNA titers inside the infected cells represent the final viral amount including the infected DNA without being degraded and the newly synthesized HBV DNA. In this way, studying the efficacy of DNA damage response inhibitors on HBV infection and replication was available. In addition, since DNA damage response is an acute response that happens quickly after virus infection, they assume that early intervention of DNA damage pathway will function more efficiently, thus can be used clinically as HBV infection therapy during its early infectious stage or fulminant HBV infection.

Source: World Journal of Gastroenterology

Explore further: US cautiously optimistic after no new Ebola in 5 days

add to favorites email to friend print save as pdf

Related Stories

US company sells out of Ebola toys

7 hours ago

They might look tasteless, but satisfied customers dub them cute and adorable. Ebola-themed toys have proved such a hit that one US-based company has sold out.

UN biodiversity meet commits to double funding

8 hours ago

A UN conference on preserving the earth's dwindling resources wrapped up Friday with governments making a firm commitment to double biodiversity aid to developing countries by 2015.

Facebook unfriends federal drug agency

8 hours ago

(AP)—Facebook wants assurances from the Drug Enforcement Administration that it's not operating any more fake profile pages as part of ongoing investigations.

Partial solar eclipse over the U.S. on Thursday, Oct. 23

8 hours ago

People in most of the continental United States will be in the shadow of the Moon on Thursday afternoon, Oct. 23, as a partial solar eclipse sweeps across the Earth. For people looking through sun-safe filters, from Los Angeles, ...

Recommended for you

Ebola: Five questions about the killer virus

36 minutes ago

The highly contagious Ebola virus, which has killed more than 4,500 people in west Africa since December and has fueled global alarm, is among the most dangerous ever identified.

Ebola fear, monitoring eases for some in Dallas

46 minutes ago

The people closest to Ebola victim Thomas Eric Duncan are trying to resume their lives now that they have come out of a 21-day incubation period without developing symptoms of the disease.

Third UN employee dies from Ebola

56 minutes ago

A UN staff member in Sierra Leone has died from Ebola, the third employee from the world organization to succumb to the deadly virus, the UN spokesman said Monday.

Canadian Ebola vaccine sent to WHO for testing

1 hour ago

The first batch of an experimental Ebola vaccine developed by Canadian scientists was sent to Switzerland on Monday for testing by the World Health Organization, officials said.

User comments : 0